Sponsor-Investigators

Ulka Vaishampayan

HCRN-GU19-385

Phase II Trial of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

Status

Open to Accrual

Cancer Types

Prostate

Locations

California, City of Hope, Froedtert & the Medical College of Wisconsin, Knight Cancer Institute at Oregon Health & Science University, Michigan, Oregon, University of Michigan Rogel Cancer Center, Winship Cancer Institute of Emory University, Wisconsin